The cAMP assay: A functional in vitro alternative to the in vivo Histamine Sensitization test

Vaccine

Volumn 28, Issue 5, 2010, Pages 1347-1352

  Hoonakker, Marieke E ^a,b   Ruiterkamp, Nicole ^a   Hendriksen, Coenraad F M ^a,b  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Histamine Sensitization test; In vitro alternative; Pertussis toxin

Indexed keywords

CYCLIC AMP; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INACTIVATED VACCINE; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL WELFARE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTAMINE SENSITIZATION TEST; IMMUNOLOGICAL TECHNIQUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY;

ANIMALS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; HUMANS; PERTUSSIS TOXIN; PERTUSSIS VACCINE; QUALITY CONTROL; RATS; SENSITIVITY AND SPECIFICITY;

EID: 74149094588     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.009     Document Type: Article

References (32)

1. Kerr J.R., and Matthews R.C. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis 19 2 (2000) 77-88
2. Mattoo S., and Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18 2 (2005) 326-382
3. Carbonetti N.H. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr Opin Pharmacol 7 3 (2007) 272-278
4. Black W.J., Munoz J.J., Peacock M.G., Schad P.A., Cowell J.L., Burchall J.J., et al. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science 240 4852 (1988) 656-659
5. Sato H., Ito A., Chiba J., and Sato Y. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect Immun 46 2 (1984) 422-428
6. European Pharmacopoeia. Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed) 01/2008: 1934. 6th ed., Version 6.4; 2009.
7. Parfentjev I.A., and Goodline M.A. Histamine shock in mice sensitized with Hemophilus pertussis vaccine. J Pharmacol Exp Ther 92 4 (1948) 411-413
8. Van Straaten-van de Kappelle I., Van der Gun J.W., Marsman F.R., Hendriksen C.F.M., and Van de Donk H.J.M. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine. Biologicals 25 1 (1997) 41-58
9. Morse S.I., and Morse J.H. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med 143 6 (1976) 1483-1502
10. Morse S.I. Lymphocytosis-promoting factor of Bordetella pertussis: isolation, characterization, and biological activity. J Infect Dis 136 (1977) S234-S238
11. Gillenius P., Jäätmaa E., Askelöf P., Granström M., and Tiru M. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand 13 1 (1985) 61-66
12. Fujiwara H., and Iwasa S. The quantitative assay of the clustering activity of the lymphocytosis-promoting factor (pertussis toxin) of Bordetella pertussis on Chinese hamster ovary (CHO) cells. J Biol Stand 17 1 (1989) 53-64
13. Cyr T., Menzies A.J., Calver J., and Whitehouse L.W. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products. Biologicals 29 2 (2001) 81-95
14. Yuen C.T., Canthaboo C., Menzies J.A., Cyr T., Whitehouse L.W., Jones C., et al. Detection of residual pertussis toxin in vaccines using a modified ribosylation assay. Vaccine 21 1-2 (2002) 44-52
15. Van Meijeren CE. Development of an in vitro assay to assess pertussis toxin in acellular pertussis vaccines. PhD thesis. Utrecht University, Utrecht; 2005.
16. Vleeming W., Hendriksen C.F., van de Kuil A., van den Hout J.W., and de Wildt D.J. Mepyramine but not cimetidine or clobenpropit blocks pertussis toxin-induced histamine sensitization in rats. Br J Pharmacol 129 8 (2000) 1801-1807
17. Van Meijeren C.E., Vleeming W., van de Kuil T., Gerards A.L., Hendriksen C.F., and de Wildt D.J. Pertussis toxin-induced histamine sensitisation: an aspecific phenomenon independent from the nitric oxide system?. Eur J Pharmacol 493 1-3 (2004) 139-150
18. Van Meijeren C.E., Vleeming W., van de Kuil T., Manni J., Kegler D., Hendriksen C.F., et al. In vivo pertussis toxin treatment reduces contraction of rat resistance arteries but not that of mouse trachea. Eur J Pharmacol 488 1-3 (2004) 127-135
19. Van Meijeren C.E., Vleeming W., Dormans J.A., van de Kuil T., Opperhuizen A., Hendriksen C.F., et al. Pertussis toxin relaxes small arteries with no vascular lesions or vascular smooth muscle cell injury. Exp Toxicol Pathol 56 3 (2004) 139-143
20. Spitzbarth-Régrigny E., Petitcolin M.A., Bueb J.L., Tschirhart E.J., Atkinson J., and Capdeville-Atkinson C. Pertussis toxin-sensitive G(i)-proteins and intracellular calcium sensitivity of vasoconstriction in the intact rat tail artery. Br J Pharmacol 131 7 (2000) 1337-1344
21. Petitcolin M.A., Spitzbarth-Régrigny E., Bueb J.L., Capdeville-Atkinson C., and Tschirhart E. Role of G(i)-proteins in norepinephrine-mediated vasoconstriction in rat tail artery smooth muscle. Biochem Pharmacol 61 9 (2001) 1169-1175
22. Gierschik P. ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin. Curr Top Microbiol Immunol 175 (1992) 69-96
23. Abdel-Latif A.A. Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp Biol Med (Maywood) 226 3 (2001) 153-163
24. Pfitzer G. Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 91 1 (2001) 497-503
25. Raymond J.R., Hnatowich M., Lefkowitz R.J., and Caron M.G. Adrenergic receptors. Models for regulation of signal transduction processes. Hypertension 15 2 (1990) 119-131
26. Iwasa S., and Fujiwara H. Comparison of the detoxification courses of the histamine-sensitizing, lymphocytosis-promoting and CHO cell-clustering activities in the process of the production of acellular pertussis vaccine. Biologicals 18 2 (1990) 127-130
27. Van Straaten-van de Kappelle I., Wiertz E.J., Marsman F.R., Borsboom D.J., van de Donk H.J., and Kreeftenberg J.G. The modified leukocytosis promoting factor (LPF)-test: a valuable supplement to the mouse weight gain (MWG)-test in toxicity control of whole cell pertussis vaccine. Biologicals 20 4 (1992) 277-282
28. Mayer S.E., Stull J.T., and Wastila W.B. Rapid tissue fixation and extraction techniques. Methods Enzymol 38 (1974) 1-9
29. Sorrentino J.A., and Millis A.J. Structural comparisons of fibronectins isolated from early and late passage cells. Mech Ageing Dev 28 1 (1984) 83-97
30. Zhang J., Patel J.M., and Block E.R. Enhanced apoptosis in prolonged cultures of senescent porcine pulmonary artery endothelial cells. Mech Ageing Dev 123 6 (2002) 613-625
31. Briske-Anderson M.J., Finley J.W., and Newman S.M. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med 214 3 (1997) 248-257
32. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., and Januarisen-Dürr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol 36 8 (2001) 1327-1347